ArticlePharmaceutics2021

Discovery of the First in Class 9-N-Berberine Derivative as Hypoglycemic Agent with Extra-Strong Action.

Mikhail V Khvostov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.